87
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Low risk for viral reactivation during induction for acute myeloid leukemia in patients with resolved hepatitis B infection

, , , & ORCID Icon
Pages 1260-1262 | Received 08 Aug 2019, Accepted 27 Nov 2019, Published online: 20 Dec 2019

References

  • Hoofnagle JH. Reactivation of hepatitis B. Hepatology. 2009;49(S5):S156–S165.
  • Tang LSY, Covert E, Wilson E, et al. Chronic hepatitis B infection: a review. JAMA. 2018;319(17):1802–1813.
  • Bessone F, Dirchwolf M. Management of hepatitis B reactivation in immunosuppressed patients: an update on current recommendations. WJH. 2016;8(8):385–394.
  • Yeo W, Chan PK, Zhong S, et al. Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors. J Med Virol. 2000;62(3):299–307.
  • Loomba R, Rowley A, Wesley R, et al. Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy. Ann Intern Med. 2008;148(7):519–528.
  • Yeo W, Chan TC, Leung NW, et al. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. JCO. 2009;27(4):605–611.
  • Seto WK, Chan TS, Hwang YY, et al. Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study. JCO. 2014;32(33):3736–3743.
  • Reddy KR, Beavers KL, Hammond SP, et al. American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy. Gastroenterology. 2015;148(1):215–219. quiz e216-217.
  • Feld JJ. Hepatitis B reactivation: the controversies continue. Dig Dis. 2017;35(4):351–358.
  • Chen CY, Huang SY, Cheng A, et al. High risk of hepatitis B reactivation among patients with acute myeloid leukemia. PLoS One. 2015;10(5):e0126037.
  • Paul S, Saxena A, Terrin N, et al. Hepatitis B virus reactivation and prophylaxis during solid tumor chemotherapy: a systematic review and meta-analysis. Ann Intern Med. 2016;164(1):30–40.
  • Chen CY, Tien FM, Cheng A, et al. Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan. BMC Gastroenterol. 2018;18(1):6.
  • Chang YT, Hernandez D, Alonso S, et al. Role of CYP3A4 in bone marrow microenvironment-mediated protection of FLT3/ITD AML from tyrosine kinase inhibitors. Blood Adv. 2019;3(6):908–916.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.